Endochoice Holdings Stock Return On Equity
EndoChoice Holdings fundamentals help investors to digest information that contributes to EndoChoice Holdings' financial success or failures. It also enables traders to predict the movement of EndoChoice Stock. The fundamental analysis module provides a way to measure EndoChoice Holdings' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to EndoChoice Holdings stock.
EndoChoice |
EndoChoice Holdings Company Return On Equity Analysis
EndoChoice Holdings' Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
CompetitionBased on the latest financial disclosure, EndoChoice Holdings has a Return On Equity of 0.0. This indicator is about the same for the average (which is currently at 0.0) sector and about the same as Return On Equity (which currently averages 0.0) industry. This indicator is about the same for all United States stocks average (which is currently at 0.0).
EndoChoice Return On Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses EndoChoice Holdings' direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of EndoChoice Holdings could also be used in its relative valuation, which is a method of valuing EndoChoice Holdings by comparing valuation metrics of similar companies.EndoChoice Holdings is currently under evaluation in return on equity category among related companies.
EndoChoice Fundamentals
Return On Asset | -0.47 | |||
Profit Margin | (0.0001) % | |||
Operating Margin | (0.0001) % | |||
Current Valuation | 201.86 M | |||
Shares Outstanding | 21.08 M | |||
Shares Owned By Insiders | 13.73 % | |||
Shares Owned By Institutions | 46.30 % | |||
Number Of Shares Shorted | 349.75 K | |||
Price To Earning | (2.96) X | |||
Price To Book | 3.28 X | |||
Price To Sales | 2.77 X | |||
Revenue | 72.3 M | |||
Gross Profit | 23.31 M | |||
Net Income | (59.38 M) | |||
Cash And Equivalents | 34.03 M | |||
Cash Per Share | 2.19 X | |||
Total Debt | 42.64 M | |||
Debt To Equity | 0.70 % | |||
Current Ratio | 5.63 X | |||
Cash Flow From Operations | (42.62 M) | |||
Earnings Per Share | (2.89) X | |||
Number Of Employees | 501 | |||
Beta | 3.49 | |||
Market Capitalization | 207.04 M | |||
Total Asset | 164.34 M | |||
Retained Earnings | (156.55 M) | |||
Working Capital | 79.83 M | |||
Current Asset | 98.37 M | |||
Current Liabilities | 18.53 M | |||
Z Score | 2.4 |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Other Consideration for investing in EndoChoice Stock
If you are still planning to invest in EndoChoice Holdings check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the EndoChoice Holdings' history and understand the potential risks before investing.
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Equity Valuation Check real value of public entities based on technical and fundamental data |